spacer gif spacer gif spacer gif spacer gif Propose a workshop for 2011 spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

First published online 6 May 2003
doi: 10.1242/jcs.00461


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jcs.00461v1
116/12/2495    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nelson, G.
Right arrow Articles by White, M. R. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nelson, G.
Right arrow Articles by White, M. R. H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
Journal of Cell Science 116, 2495-2503 (2003)
doi: 10.1242/jcs.00461


Research Article

NF-{kappa}B signalling is inhibited by glucocorticoid receptor and STAT6 via distinct mechanisms

Glyn Nelson1, Geraint J. C. Wilde1, David G. Spiller1, Stephnie M. Kennedy1, David W. Ray2, Elaine Sullivan3, John F. Unitt3 and Michael R. H. White1,*

1 Biosciences Building, School of Biological Sciences, University of Liverpool, Crown Street, Liverpool L69 7ZB, UK
2 Department of Medicine, University of Manchester, Stopford Building, Manchester M13 9PT, UK
3 Lead Generation, Molecular Biology, AstraZeneca R&D Charnwood, Bakewell Road, Loughborough LE11 5RH, UK

* Author for correspondence (e-mail: mwhite{at}liv.ac.uk)

Accepted 6 March 2003

NF-{kappa}B transcription factors are involved in the cellular response to stress, and are regulated by inhibitor (I{kappa}B) proteins, which prevent NF-{kappa}B-mediated transcription by maintaining NF-{kappa}B in the cytoplasm. Proteins from other pathways are also known to regulate NF-{kappa}B negatively, notably the glucocorticoid receptor (GR) and IL-4-responsive STAT6. Both pathways were shown to inhibit NF-{kappa}B-mediated transcription, by expressing either STAT6 or GR and activating the respective pathways. Using fluorescent fusion proteins, we show that GR alters the timing of activated p65 NF-{kappa}B nuclear occupancy by increasing the export rate of p65 and is independent of whether GR is present as a dimer or monomer. Expression of STAT6 was also shown to alter p65 nuclear occupancy but appeared to affect the import rate and hence the overall maximal level of p65 translocation. Activating STAT6 with IL-4 prior to activating NF-{kappa}B significantly increased this inhibition. Investigation of I{kappa}Ba showed that activated STAT6 inhibited TNF{alpha}-mediated I{kappa}Ba phosphorylation and degradation, whereas GR activation did not alter I{kappa}B{alpha}kinetics. This demonstrates a clear separation of two distinct mechanisms of inhibition by STAT6 and GR upon the NF-{kappa}B pathway.

Key words: NF-{kappa}B, STAT6, Glucocorticoid receptor, Signal transduction, Fluorescent protein fusions, Confocal microscopy


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
J EndocrinolHome page
K. L A Souza, E. Gurgul-Convey, M. Elsner, and S. Lenzen
Interaction between pro-inflammatory and anti-inflammatory cytokines in insulin-producing cells
J. Endocrinol., April 1, 2008; 197(1): 139 - 150.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. P. Chapoval, A. Al-Garawi, J. M. Lora, I. Strickland, B. Ma, P. J. Lee, R. J. Homer, S. Ghosh, A. J. Coyle, and J. A. Elias
Inhibition of NF-{kappa}B Activation Reduces the Tissue Effects of Transgenic IL-13
J. Immunol., November 15, 2007; 179(10): 7030 - 7041.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
A. McMaster and D. W. Ray
Modelling the glucocorticoid receptor and producing therapeutic agents with anti-inflammatory effects but reduced side-effects
Exp Physiol, March 1, 2007; 92(2): 299 - 309.
[Abstract] [Full Text] [PDF]


Home page
J R Soc InterfaceHome page
H. Shen, G. Nelson, D. E Nelson, S. Kennedy, D. G Spiller, T. Griffiths, N. Paton, S. G Oliver, M. R.H White, and D. B Kell
Automated tracking of gene expression in individual cells and cell compartments
J R Soc Interface, December 22, 2006; 3(11): 787 - 794.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Marcais, C.-A. Coupet, T. Walzer, M. Tomkowiak, R. Ghittoni, and J. Marvel
Cell-Autonomous CCL5 Transcription by Memory CD8 T Cells Is Regulated by IL-4
J. Immunol., October 1, 2006; 177(7): 4451 - 4457.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. J. M. Schaaf, L. Willetts, B. P. Hayes, B. Maschera, E. Stylianou, and S. N. Farrow
The Relationship between Intranuclear Mobility of the NF-{kappa}B Subunit p65 and Its DNA Binding Affinity
J. Biol. Chem., August 4, 2006; 281(31): 22409 - 22420.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. P. Kirton, F. L. Wilkinson, A. E. Canfield, and M. Y. Alexander
Dexamethasone Downregulates Calcification-Inhibitor Molecules and Accelerates Osteogenic Differentiation of Vascular Pericytes: Implications for Vascular Calcification
Circ. Res., May 26, 2006; 98(10): 1264 - 1272.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. Friedrichsen, C. V. Harper, S. Semprini, M. Wilding, A. D. Adamson, D. G. Spiller, G. Nelson, J. J. Mullins, M. R. H. White, and J. R. E. Davis
Tumor Necrosis Factor-{alpha} Activates the Human Prolactin Gene Promoter via Nuclear Factor-{kappa}B Signaling
Endocrinology, February 1, 2006; 147(2): 773 - 781.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
D. E. Nelson, C. A. Horton, V. See, J. R. Johnson, G. Nelson, D. G. Spiller, D. B. Kell, and M. R. H. White
Response to Comment on "Oscillations in NF-{kappa}B Signaling Control the Dynamics of Gene Expression"
Science, April 1, 2005; 308(5718): 52b - 52b.
[Full Text] [PDF]


Home page
ScienceHome page
D. E. Nelson, A. E. C. Ihekwaba, M. Elliott, J. R. Johnson, C. A. Gibney, B. E. Foreman, G. Nelson, V. See, C. A. Horton, D. G. Spiller, et al.
Oscillations in NF-{kappa}B Signaling Control the Dynamics of Gene Expression
Science, October 22, 2004; 306(5696): 704 - 708.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Wang, M. G. Malabarba, Z. S. Nagy, and R. A. Kirken
Interleukin 4 Regulates Phosphorylation of Serine 756 in the Transactivation Domain of Stat6: ROLES FOR MULTIPLE PHOSPHORYLATION SITES AND Stat6 FUNCTION
J. Biol. Chem., June 11, 2004; 279(24): 25196 - 25203.
[Abstract] [Full Text] [PDF]




© The Company of Biologists Ltd 2003